Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: FEBS J. 2018 Dec 22;286(1):82–109. doi: 10.1111/febs.14728

Table 13:

RNA-seq patient sample composition

Group Replicate Age (weeks gestation) and Sex # of Cells used in RNA-seq
U1 1 37F, 39.57M, 37.86F 1.7×105
U2 2 40.43F, 38.86M, 39.14F 1.8×105
U3 3 37.86F, 40.14M, 37F 1.6×105
L1 1 37F, 39.57M, 37.86F 1.7×105
L2 2 40.43F, 38.86M, 39.14F 1.8×105
L3 3 37.86F, 40.14M, 37F 1.6×105
CU1 1 38.14F, 41F, 40.43M 1.3×105
CU2 2 39.86F, 38.14M, 38.14M 1.6×105
CU3 3 41.14F, 41.14M, 40.57F 1.7×105
CL1 1 38.14F, 41F, 40.43M 1.3×105
CL2 2 39.86F, 38.14M, 38.14M 1.6×105
CL3 3 41.14F, 41.14M, 40.57F 1.7×105

U=healthy unstimulated monocytes, L=healthy LPS stimulated monocytes, CU=chorioamnionitis-exposed unstimulated monocytes, CL=chorioamnionitis-exposed LPS stimulated monocytes, M=male, F=female